Prevention of mutagenesis: new potential mechanisms of metformin action in neoplastic cells
- PMID: 22491515
- DOI: 10.1158/1940-6207.CAPR-12-0085
Prevention of mutagenesis: new potential mechanisms of metformin action in neoplastic cells
Abstract
Several experimental and epidemiologic studies have shown that the antidiabetes drug metformin has antitumor properties. The report by Algire and colleagues in this issue of the journal (beginning on page 536) shows for the first time that metformin reduces mutagenesis induced by reactive oxygen species. This report offers new perspectives on metformin in cancer prevention and provides a new mechanism for the reduction of cancer risk in diabetic patients treated with this drug.
2012 AACR
Comment on
-
Metformin reduces endogenous reactive oxygen species and associated DNA damage.Cancer Prev Res (Phila). 2012 Apr;5(4):536-43. doi: 10.1158/1940-6207.CAPR-11-0536. Epub 2012 Jan 18. Cancer Prev Res (Phila). 2012. PMID: 22262811
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
